Please provide your email address to receive an email when new articles are posted on . SelectION’s lead compound, si-544, was well tolerated up to the highest dose levels. 75% of patients saw disease ...
A team of University of Michigan researchers has successfully modified a naturally occurring chemical compound in the lab, resulting in advanced lead compounds with anti-HIV activity. Their results, ...
WOODS CROSS, Utah--(BUSINESS WIRE)--Phoenix PharmaLabs, Inc. (https://www.phoenixpharmalabs.com), a private company developing potent, non-addictive treatments for pain and substance abuse disorders, ...
The promise of immunotherapy lies in its ability to harness the body's own immune defenses to recognize and destroy malignant cells LB-100, the lead compound developed by LIXTE Biotechnology, is part ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results